Evidence map›Paper›PMID 35202656›Full record

ArticleThe Journal of biological chemistry2022

Expanding polysaccharide-protein coupling of glycoconjugate vaccines.

Francesco Berti

Open access · goldAbstract readComment
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Francesco BertiGSK Vaccines S.r.l., Technical R&D, Siena, Italy. Electronic address: francesco.x.berti@gsk.com.
GlaxoSmithKline (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the preparation of glycoconjugate vaccines, polysaccharide antigens can usually be chemically modified to generate reactive functional groups (e.g., the formation of aldehyde groups by periodate oxidation of adjacent diols) for covalent coupling with proteins. In a recent issue of JBC, Duke et al. showed that an alternative agent, galactose oxidase (GOase) isolated from the fungus Fusarium sp. can generate aldehyde groups in a unique chemoenzymatic approach to prepare a conjugate vaccine against Streptococcus pneumoniae. These findings introduce a new strategy for the design and development of glycoconjugate vaccines.

Indexed as

GlycoconjugatesPolysaccharidesStreptococcus pneumoniaeVaccines, ConjugateAldehydesPolysaccharides, BacterialAldehydesGlycoconjugatesPolysaccharidesPolysaccharides, BacterialVaccines, Conjugatecapsular polysaccharidechemoenzymatic reactiongalactose oxidaseglycoconjugate vaccine

Identifiers

PMID35202656
PMCPMC8914364
OpenAlexW4213299902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.